What sequences must be included in a “Sequence Listing XML”?
According to MPEP 2412.03, the following sequences must be included in a “Sequence Listing XML”: Unbranched sequences or linear regions of branched sequences containing 4 or more specifically defined amino acids forming a single peptide backbone Unbranched sequences or linear regions of branched sequences of 10 or more specifically defined nucleotides joined by phosphodiester linkages…
Read MoreWhat sequences are excluded from a Sequence Listing XML?
According to MPEP 2412.03, certain sequences must be excluded from a Sequence Listing XML: Sequences having fewer than 10 specifically defined nucleotides Sequences having fewer than 4 specifically defined amino acids The MPEP cites 37 CFR 1.831(j), which states: A “Sequence listing XML” must not include any sequences having fewer than 10 specifically defined nucleotides,…
Read MoreWhat types of sequences are covered by the Sequence Rules?
The Sequence Rules apply to certain types of nucleotide and amino acid sequences disclosed in patent applications. According to MPEP 2412.01, the rules cover “certain nucleotide and/or amino acid sequences disclosed in patent applications.” The specific definition of which sequences are covered is provided in 37 CFR 1.831(b). Generally, this includes sequences of a specified…
Read MoreWhat are the Sequence Rules in patent applications?
The Sequence Rules are a set of regulations that define how nucleotide and amino acid sequences must be presented in patent applications. According to MPEP 2421.02, these rules “define a set of symbols and procedures that are both mandatory and the only way that an applicant is permitted to describe information in the ‘Sequence Listing’…
Read MoreWhen do the Sequence Rules apply to patent applications?
The Sequence Rules apply to patent applications containing nucleotide sequence and/or amino acid sequence disclosures filed under WIPO ST.25. However, it’s important to note that there’s a cutoff date for the applicability of these rules. According to MPEP 2420: “[Editor Note: This section is not applicable to applications filed on or after July 1, 2022,…
Read MoreHow are nucleotide and amino acid sequences represented in patent applications?
According to MPEP 2422.01, nucleotide and amino acid sequences in patent applications are represented as follows: Nucleotide sequences: Represented by symbols set forth in 37 CFR 1.822(b) and Appendices A and B to 37 CFR part 1, Subpart G. Amino acid sequences: Limited to those in 37 CFR 1.822(b) and Appendices C and D to…
Read MoreWhat are the requirements for sequence listings in patent applications?
The requirements for sequence listings in patent applications are outlined in MPEP 2422.02: All sequences that meet the length thresholds (10 or more nucleotides or 4 or more amino acids) must be included in the sequence listing. The sequence listing must be submitted as a separate part of the disclosure. Each sequence must be assigned…
Read MoreWhat is a “Sequence Listing XML” and when is it required?
A “Sequence Listing XML” is a standardized format for presenting nucleotide and/or amino acid sequences in patent applications. It is required for all applications filed on or after July 1, 2022, that have disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). The XML format ensures that sequence information is machine-readable…
Read MoreWhat are the requirements for submitting a “Sequence Listing XML” in patent applications?
According to MPEP 2416, patent applications filed on or after July 1, 2022, that contain disclosures of nucleotide and/or amino acid sequences must include a “Sequence Listing XML” as a separate part of the disclosure. This XML file must be submitted in one of two ways: Via the USPTO’s patent electronic filing system (Patent Center)…
Read MoreWhen is a Sequence Listing in XML format required for patent applications?
A Sequence Listing in XML format is required for patent applications filed on or after July 1, 2022, that disclose nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). The MPEP states: “An application that has a filing date on or after July 1, 2022, will be required to provide a ‘Sequence Listing…
Read More